Can I Get a Michigan Medical Marijuana Card for Severe Nausea?
Persistent severe nausea from chronic disease or medical treatment.
Yes — severe nausea qualifies under the Michigan Medical Marihuana Program
Severe nausea is explicitly listed as a Category B qualifying criterion on the Michigan MMMP Physician Certification Form. Any chronic or debilitating disease or its treatment that produces severe nausea qualifies the patient. This is most often invoked for chemotherapy-induced nausea, antiretroviral therapy side effects, gastroparesis, cyclic vomiting syndrome, or chronic gastrointestinal disease. Cannabis has one of the strongest evidence bases for nausea of any medical indication.
Common symptoms
- Persistent or recurrent severe nausea
- Vomiting interfering with eating, drinking, or medication adherence
- Weight loss or dehydration
- Reduced quality of life
- Often associated with chemotherapy, antiretroviral therapy, gastroparesis, migraine, or chronic GI disease
How medical cannabis may help
THC binds CB1 receptors in the brainstem antiemetic pathway, producing antiemetic effects strong enough that the FDA approved synthetic THC (dronabinol) and synthetic nabilone (Cesamet) for chemotherapy-induced nausea and vomiting. Many patients find inhaled or sublingual cannabis particularly useful for breakthrough nausea — the rapid onset of inhaled cannabis matches the timing needed when nausea is sudden or unpredictable. CBD also has antiemetic properties, particularly for anticipatory nausea.
Evidence base
The FDA approval of dronabinol (1985) and nabilone (1985) for chemotherapy-induced nausea is supported by multiple randomized controlled trials. The 2017 NASEM report classified evidence for cannabis/cannabinoids in chemotherapy-induced nausea as "conclusive evidence" — the highest evidence category the report assigned. Subsequent guidelines (American Society of Clinical Oncology, NCCN) have positioned cannabinoids as second- or third-line antiemetics for refractory chemotherapy nausea.
Michigan certification requirements
Documentation of the underlying chronic disease causing severe nausea (cancer, HIV, gastroparesis, etc.) plus a description of nausea severity and impact on daily function is helpful. A list of antiemetics already tried (ondansetron, prochlorperazine, metoclopramide, etc.) is useful.
Frequently Asked Questions
- Can I qualify if my severe nausea is from chemotherapy?
- Yes. Chemotherapy-induced nausea is one of the most common Category B qualifying scenarios. Cannabis has FDA-approved analogues (dronabinol, nabilone) specifically for this indication. Cancer is also independently a Category A qualifying condition.
- What about cyclic vomiting syndrome or cannabis hyperemesis?
- Cyclic vomiting syndrome can qualify under Category B (severe nausea). However, cannabis hyperemesis syndrome — a rare paradoxical reaction in heavy chronic cannabis users — is a contraindication. Dr. Vance will discuss your specific symptom pattern during the consultation.
